Association of leucine pathway metabolites with moyamoya disease and its clinical phenotypes. [PDF]
Fu M +7 more
europepmc +1 more source
Inflammatory and cardiac-stress biomarkers in Moyamoya disease: the role of GDF-15. [PDF]
Guo F +5 more
europepmc +1 more source
How retinal artery occlusion reveals moyamoya disease-a case series and descriptive study. [PDF]
Li ZY, Li Y, Wang YQ, Chen T, Xiao X.
europepmc +1 more source
Moyamoya disease masquerading as CNS vasculitis: Diagnostic challenges and imaging insights. [PDF]
Saad AM +7 more
europepmc +1 more source
7 T MRI in moyamoya disease: current evidence and AI-assisted future directions-a narrative review. [PDF]
Wu H +6 more
europepmc +1 more source
STK39 is associated with endothelial dysfunction and inflammatory activation under hypoxic conditions in moyamoya disease. [PDF]
Liang R +6 more
europepmc +1 more source
Advances in cerebrovascular reserve function assessment for moyamoya disease. [PDF]
Chen S +10 more
europepmc +1 more source
Early vascular lesion tracking in moyamoya disease: A case report with serial findings. [PDF]
Yokoyama S +7 more
europepmc +1 more source
Enhanced Recovery After Surgery Consensus Protocol for Cerebral Bypass in Moyamoya Disease. [PDF]
Hallan D +10 more
europepmc +1 more source
An unusual presentation of Moyamoya disease managed conservatively in a resource limited region: A case report. [PDF]
Tabassum Z +7 more
europepmc +1 more source

